At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
DRS probedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Development and Validation of a Tumour Oxygenation Monitoring Probe
In Brief
An observational study evaluating DRS probe for Cancer. Completed, enrolled 20 participants across 1 site.
Detailed Summary
Laboratory based study in which novel tissue oxygenation probe with the potential provide novel means for assessing response to cancer treatment will be developed and validated.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCancer
CountriesUnited Kingdom
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedJun 2019
Enrollment StartAug 2019
Primary CompletionJun 2020
TodayJul 2026
First PostedJun 11, 2019
Enrollment StartAug 9, 2019
Primary CompletionJun 30, 2020
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 7.1 years ago
Interventions
DRS probedevice
The Oxygenation measurements of the novel diffuse reflectance spectroscopy probe